New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cosmos Health Inc.
COSM
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

15M

Drug Manufacturers - Specialty & Generic

Next Earning date - 19 Nov 2024

15M

Drug Manufacturers - Specialty & Generic

Next Earning date - 19 Nov 2024

0.74USD
Shape-0.04 ( -5.21%)
Market Open
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-79%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

55%

Quote Panel

Shape
Updated October 29, 2024
1W -0.49 % 1M -15.96 % 3M -38.65 % 1Y -28.52 %

Key Metrics

Shape
  • Market Cap

    15.47M


  • Shares Outstanding

    21.01M


  • Share in Float

    19.12M


  • Dividende

    0


  • Earning Date

    19 Nov 2024


  • Price Target

    0.7361


  • Average Volume

    487231


  • Beta

    3.117


  • Range

    0.468-1.65


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cosmosholdingsinc.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.28x

P/S Ratio

0.41x

P/B Ratio

0.4

Debt/Equity

-38.2%

Net Margin

$-2.3

EPS

How COSM compares to sector?

P/E Ratio

Relative Strength

Shape

COSM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$69M

Shape422%

2025-Revenue

$0.05

Shape67%

2025-EPS

$8M

Shape-273%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-2.00
vs -2.15

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

-0.04
vs 0.29

Q2.23

arrow
arrow

+100%

0.02
vs -23.25

Q3.23

arrow
arrow

N/A

-0.09
vs -2.00

Q4.23

arrow
arrow

N/A

NA
vs NA

Q1.24

arrow
arrow

N/A

-0.11
vs -0.04

Q2.24

arrow
arrow

N/A

-0.04
vs 0.02

Q3.24

arrow
arrow

N/A

-0.11
vs -0.09

Q1.25

arrow
arrow

N/A

-0.07
vs -0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-12%

12M  vs 13.6M

Q4.22

arrow
arrow

-26%

12.1M  vs 16.2M

Q1.23

arrow
arrow

-6%

12.3M  vs 13.1M

Q2.23

arrow
arrow

-6%

12.4M  vs 13.2M

Q3.23

arrow
arrow

+7%

12.8M  vs 12M

Q4.23

arrow
arrow

+31%

15.8M  vs 12.1M

Q1.24

arrow
arrow

+18%

14.6M  vs 12.3M

Q2.24

arrow
arrow

+7%

13.2M  vs 12.4M

Q3.24

arrow
arrow

+9%

14M  vs 12.8M

Q1.25

arrow
arrow

+6%

15.5M  vs 14.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-38%

-0.38
vs -0.15

Q4.22

arrow
arrow

-27%

-0.27
vs -0.38

Q1.23

arrow
arrow

-1%

-0.01
vs -0.27

Q2.23

arrow
arrow

-2%

-0.02
vs -0.01

Q3.23

arrow
arrow

-8%

-0.08
vs -0.02

Q4.23

arrow
arrow

-38%

-0.38
vs -0.08

Q1.24

arrow
arrow

-5%

-0.05
vs -0.38

Q2.24

arrow
arrow

-8%

-0.08
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q4.20

arrow
arrow

1

1
vs NA

NA

Q1.22

arrow
arrow

4

4
vs NA

NA

Q2.22

arrow
arrow

6

6
vs 4

50%

Q3.22

arrow
arrow

7

7
vs 6

17%

Q4.23

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News